IMU 3.77% 5.1¢ imugene limited

Ann: Clinical Cancer Research Journal publish B-Vaxx Phase 1 Data, page-3

  1. 12,324 Posts.
    lightbulb Created with Sketch. 3772
    So, B-Vaxx not dead at all. 

    We got now 2 vaxx in the trials with HerVaxx already outperforming anything available at relevant developing stages and now we learn that even B-Vaxx, developed before HerVaxx, is showing fantastic results compared to the T-cell products. And to top that, the even more advanced KeyVaxx is to hit the clinics soon. And a MC of just 60m including at least 15m in cash, assuming some has been spent since December from the 20m plus.

    Sp today 1.5c due to excellent news, ASX morons, come on, let's crash it lower.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.1¢
Change
-0.002(3.77%)
Mkt cap ! $373.3M
Open High Low Value Volume
5.2¢ 5.2¢ 5.0¢ $669.7K 13.07M

Buyers (Bids)

No. Vol. Price($)
6 1074997 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
5.2¢ 1209633 6
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.